Home> Products> long term epilepsy treatment sodium valproate

{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6790bd2262059c5632ce4d2d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Magnesium Valproate 200mg", "description": "VALPOTREAT MAG 200 is a specially formulated medication containing Magnesium Valproate in a controlled-release tablet. It is widely prescribed to manage and control various neurological conditions such as epilepsy and bipolar disorder. Designed for effective absorption and consistent therapeutic effects, this medication helps stabilize mood and prevent seizures, improving the quality of life for those dealing with these conditions.\n\n \nKey Benefits:\n \n\nSeizure Control: Effective in preventing and managing various types of seizures, including absence seizures, generalized tonic-clonic seizures, and complex partial seizures.\nMood Stabilization: Provides relief from mood swings and supports emotional balance in patients with bipolar disorder.\nControlled Release: Ensures gradual absorption, reducing fluctuations in drug levels and minimizing side effects.\nNeurological Support: Enhances brain health and stabilizes nerve impulses, making it an essential treatment for epilepsy and related conditions.\nBetter Tolerability: The addition of magnesium reduces gastrointestinal discomfort, often associated with other valproate formulations.\n \nHow Does It Work?\n \n\nMagnesium Valproate works by increasing the availability of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that calms nerve activity. By stabilizing neuronal firing, it prevents excessive electrical discharges that lead to seizures. Additionally, it balances neurotransmitters involved in mood regulation, making it effective for managing bipolar disorder. The controlled-release formulation ensures consistent drug levels, offering prolonged symptom control while minimizing side effects.\n\n \nDirections for Use:\n \n\nDosage: Take the dose as prescribed by your healthcare provider, usually once or twice daily.\nWith Food: To minimize gastrointestinal irritation, take the tablet with or after meals.\nSwallow Whole: Do not crush or chew the tablet to preserve the controlled-release properties.\nConsistency: Take the medication at the same time each day for optimal effectiveness.\nMissed Dose: If a dose is missed, take it as soon as you remember. Skip the missed dose if it’s close to the next scheduled dose.\n \nSide Effects:\n \n\nWhile VALPOTREAT MAG 200 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nCommon Side Effects: Nausea, vomiting, dizziness, drowsiness, and abdominal discomfort.\nRare Side Effects: Tremors, weight changes, hair loss, and temporary changes in liver enzyme levels.\nSevere Reactions: In rare cases, severe allergic reactions, unusual bleeding, or behavioral changes may occur. If these symptoms arise, seek immediate medical attention.", "price": 78.0, "discountamount": 24.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "missed dose", "effective absorption", "widely prescribed", "controlledrelease tablet", "medical attention", "hair loss", "experience mild", "generally welltolerated", "valpotreat mag 200", "remember skip", "meals swallow", "healthcare provider", "seizures additionally", "valproate formulations", "related conditions", "essential treatment", "drug levels", "neurological conditions", "magnesium valproate", "mood swings", "managing bipolar disorder", "prevent seizures improving", "specially formulated medication", "controlledrelease properties consistency", "mood regulation making", "symptoms arise seek", "moderate side effects", "minimize gastrointestinal irritation", "balances neurotransmitters involved", "stabilizing neuronal firing", "calms nerve activity", "gammaaminobutyric acid gaba", "supports emotional balance", "consistent therapeutic effects", "bipolar disorder designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2035, "imageuri": "https://productimages.withfloats.com/actual/6790bd322323937ff0a17443.png", "tileimageuri": "https://productimages.withfloats.com/tile/6790bd322323937ff0a17443.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-22T09:40:50.336Z", "updatedon": "2025-01-22T09:40:50.336Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magnesium-valproate-200mg/2035", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT MAG 200 ", "category": "neurology", "tags": [ "Magnesium valproate vs sodium valproate", "Magnesium valproate prolonged release tablets", "Magnesium valproate Wikipedia", "Magnesium valproate side effects", "Magnesium valproate Brand Name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6741b133971fb991258967eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Calcium Polystyrene Sulphate Oral Suspension 15g/60 ml", "description": "POLYSTERN Oral Suspension is an effective medication designed to treat elevated potassium levels in the blood, a condition known as hyperkalemia. This oral suspension contains Calcium Polystyrene Sulphate, a key ingredient that helps in the removal of excess potassium from the body. POLYSTERN provides a safe and convenient way to manage hyperkalemia, helping to protect the heart and other organs from the harmful effects of high potassium levels. It is often prescribed to patients who are experiencing kidney dysfunction or taking medications that may raise potassium levels.\n\n \nKey Benefits:\n \n\nEffective Treatment of Hyperkalemia\nPOLYSTERN is primarily used to reduce high potassium levels in the blood, which can cause serious health issues like heart arrhythmias, muscle weakness, and even cardiac arrest.\n\nSafe for Long-Term Use\nThe calcium form of Polystyrene Sulphate in POLYSTERN offers a safer alternative for long-term use compared to sodium-based potassium-binding resins, which can increase sodium levels in the body.\n\nSupports Kidney Function\nPOLYSTERN is particularly useful for patients with kidney problems, as it helps lower potassium levels in individuals whose kidneys may not be able to excrete enough potassium on their own.\n\nConvenient Dosage Form\nPOLYSTERN comes in an easy-to-administer oral suspension, making it suitable for both adults and children who may have difficulty swallowing tablets or capsules.\n\nNon-Invasive\nAs an oral suspension, it offers a non-invasive treatment option for managing hyperkalemia, unlike other treatments that may require intravenous administration.\n\n \nHow Does It Work?\n \n\nPOLYSTERN works by utilizing Calcium Polystyrene Sulphate to absorb excess potassium in the gastrointestinal tract. Once ingested, the resin binds to potassium ions and forms an insoluble complex that cannot be absorbed into the bloodstream. This complex is then eliminated from the body through bowel movements, effectively reducing the potassium levels in the blood. By lowering the potassium concentration in the bloodstream, POLYSTERN helps prevent complications related to hyperkalemia, such as heart arrhythmias, and supports the body’s overall electrolyte balance.\n\n \nDirections for Use:\n \n\nDosage: The typical dose of POLYSTERN Oral Suspension is 15g per 60ml, but the exact dosage will depend on the severity of the hyperkalemia and the patient’s overall health condition.\n\nAdministration: Shake the bottle well before use. The suspension can be taken directly by mouth or mixed with a small amount of water or juice if preferred.\n\nFrequency: POLYSTERN is generally taken one to three times a day, depending on the doctor’s instructions and the severity of potassium elevation. It is important to follow the prescribed dosage and schedule carefully.\n\nConsultation: Always consult with a healthcare professional before starting POLYSTERN, particularly for individuals with kidney or heart problems, or for those taking medications that might interact with the suspension.\n\n \nSide Effects:\n \n\nWhile POLYSTERN is generally well-tolerated, some individuals may experience side effects. Common side effects may include:\n\nGastrointestinal Issues:\n\nConstipation\nNausea or vomiting\nAbdominal discomfort or bloating\nElectrolyte Imbalances:\n\nAlthough POLYSTERN is designed to remove potassium, it may also affect other electrolytes like calcium and sodium. This can lead to issues such as hypocalcemia (low calcium levels), particularly if used for prolonged periods. Regular monitoring of electrolyte levels is recommended.\nDiarrhea:\n\nSome patients may experience mild diarrhea, especially if they have a sensitivity to the resin.\nAllergic Reactions:\n\nRarely, some people may have an allergic reaction to the components in POLYSTERN, which can result in symptoms like rash, itching, or swelling. If any signs of an allergic reaction appear, seek medical attention immediately.\nDehydration:\n\nDue to the changes in electrolyte balance, dehydration may occur, so it is essential to stay adequately hydrated while using this medication.", "price": 185.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "prescribed dosage", "generally welltolerated", "insoluble complex", "polystern offers", "health issues", "body polystern", "heart problems", "exact dosage", "heart arrhythmias", "hyperkalemia polystern", "rash itching", "allergic reaction", "starting polystern", "healthcare professional", "doctors instructions", "day depending", "small amount", "typical dose", "resin binds", "gastrointestinal tract", "kidney problems", "safer alternative", "calcium form", "taking medications", "key ingredient", "remove potassium", "potassium elevation", "potassium concentration", "potassium ions", "recommended diarrhea", "capsules noninvasive", "harmful effects", "oral suspension", "potassium levels", "excess potassium", "polystyrene sulphate", "electrolyte levels", "polystern oral suspension", "calcium polystyrene sulphate", "effective medication designed", "increase sodium levels", "absorb excess potassium", "high potassium levels", "suspension side effects", "managing hyperkalemia unlike", "manage hyperkalemia helping", "preferred frequency polystern", "work polystern works", "cardiac arrest safe", "experiencing kidney dysfunction", "experience mild diarrhea", "noninvasive treatment option", "electrolyte balance dehydration", "bloating electrolyte imbalances", "electrolyte balance directions", "stay adequately hydrated", "vomiting abdominal discomfort", "schedule carefully consultation", "require intravenous administration", "difficulty swallowing tablets", "sodiumbased potassiumbinding resins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2013, "imageuri": "https://productimages.withfloats.com/actual/6741b136fe463e83c8a3ddeb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6741b136fe463e83c8a3ddeb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-11-23T10:40:51.902Z", "updatedon": "2024-11-23T10:40:51.902Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/calcium-polystyrene-sulphate-oral-suspension-15g-60-ml/2013", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "POLYSTERN ORAL SUSPENSION ", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122e4d3a73cc5cb26a04de", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sacubitril (12 mg), Valsartan (13 mg)", "description": "SACUSMART 25 is a potent medication used in the treatment of chronic heart failure. It combines two essential active ingredients, Sacubitril (12 mg) and Valsartan (13 mg), working synergistically to improve heart function and reduce the risk of hospitalization due to heart failure. This combination medication belongs to the class of drugs known as ARNI (Angiotensin Receptor-Neprilysin Inhibitors) and is widely prescribed to manage heart failure symptoms, enhance quality of life, and prolong survival in patients with reduced ejection fraction.\n\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 25 enhances the ability of the heart to pump blood more efficiently, reducing symptoms of heart failure such as breathlessness and fatigue.\n\nReduces Hospitalization Risk: By improving heart function and preventing fluid buildup, SACUSMART 25 significantly reduces the likelihood of heart failure-related hospitalizations.\n\nLowers Blood Pressure: The combination of Sacubitril and Valsartan effectively lowers blood pressure, which helps reduce the strain on the heart and prevent further complications.\n\nEnhances Quality of Life: By managing the symptoms of heart failure, SACUSMART 25 helps patients lead a more active and comfortable life.\n\nLong-term Survival: Studies show that the combination therapy of Sacubitril and Valsartan can improve survival rates in patients with chronic heart failure compared to traditional therapies.\n\n \n\nHow Does It Work?\n \n\nSACUSMART 25 works by targeting two critical pathways in the regulation of blood pressure and heart function:\n\nSacubitril’s Role: As a neprilysin inhibitor, Sacubitril prevents the breakdown of natriuretic peptides, which are proteins that promote blood vessel dilation, sodium excretion, and reduced blood pressure. This leads to a decreased workload on the heart, allowing it to function more efficiently and with less strain.\n\nValsartan’s Role: Valsartan, as an angiotensin II receptor blocker, inhibits the action of angiotensin II, a hormone responsible for vasoconstriction (narrowing of blood vessels). By blocking this effect, Valsartan helps blood vessels remain relaxed, improving blood flow and reducing blood pressure.\n\nTogether, these mechanisms improve cardiac function, reduce blood pressure, and enhance the overall cardiovascular health of patients with heart failure.\n\n \n\nDirections for Use:\n \nDosage: SACUSMART 25 should be taken exactly as prescribed by a healthcare provider, typically once or twice daily, depending on the severity of the heart condition.\n\nAdministration: The tablet should be swallowed whole with water, with or without food. It's important not to crush or chew the tablet as this could affect the release and absorption of the medication.\n\nMissed Dose: If a dose is missed, take it as soon as possible unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one.\n\nRegular Monitoring: Patients should regularly monitor their blood pressure and kidney function, as SACUSMART 25 can lower blood pressure significantly and may affect kidney health.\n\n \n\nSide Effects:\n \n\nWhile SACUSMART 25 is generally well-tolerated, some individuals may experience side effects. It’s important to be aware of these potential reactions and consult a doctor if they occur.\n\nCommon Side Effects:\nLow blood pressure (hypotension)\nDizziness or lightheadedness\nElevated potassium levels (hyperkalemia)\nCough\nFatigue\n", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "blood flow", "less strain", "Key Benefits", "Cough Fatigue", "fluid buildup", "blood vessels", "kidney health", "survival rates", "heart function", "kidney function", "heart condition", "comfortable life", "cardiac function", "sodium excretion", "potent medication", "ejection fraction", "Long-term Survival", "Regular Monitoring", "Low blood pressure", "combination therapy", "potential reactions", "healthcare provider", "next scheduled dose", "Common Side Effects", "Hospitalization Risk", "natriuretic peptides", "traditional therapies", "chronic heart failure", "blood vessel dilation", "two critical pathways", "combination medication", "heart failure symptoms", "Elevated potassium levels", "overall cardiovascular health", "angiotensin II receptor blocker", "two essential active ingredients", "heart failure-related hospitalizations", "Angiotensin Receptor-Neprilysin Inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1995, "imageuri": "https://productimages.withfloats.com/actual/67122e531e1ad5a3231ccd27.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122e531e1ad5a3231ccd27.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:45:49.363Z", "updatedon": "2024-10-18T09:45:49.363Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacubitril-12-mg-valsartan-13-mg-/1995", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUSMART 25 ", "category": "CARDIOLOGYRANGE", "tags": [ "Sacubitril/valsartan", "sacubitril/valsartan tablets 50 mg uses", "Sacubitril Valsartan brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0efb162db0236048ba8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 300 ", "description": "VALPOTREAT CR 300 \nSodium Valproate CR 300 mg\nIntroduction:\n\nVALPOTREAT CR 300 contains Sodium Valproate, a highly effective anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 300mg, VALPOTREAT CR 300 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 300 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 300 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 300 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 300 for adults typically starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 300 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-300-134219", "price": 78.0, "discountamount": 23.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "time", "food", "need", "EMAIL", "brain", "water", "adults", "option", "quality", "patients", "Benefits", "severity", "epilepsy", "adherence", "two doses", "frequency", "medication", "information", "mood swings", "Introduction", "initial dose", "sterisonline", "sterispharma", "tolerability", "GABA) levels", "Key Features", "various types", "CALL/WHATSAPP", "overall health", "Initial Dosage", "patient safety", "mood stability", "manic episodes", "steady release", "liver function", "mood stabilizer", "dosage strength", "symptom control", "frequent dosing", "bipolar disorder", "absence seizures", "seizure episodes", "neuronal activity", "treatment regimen", "clinical response", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "long-term management", "therapeutic efficacy", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "effective anticonvulsant", "complex partial seizures", "typical maintenance dose", "favorable safety profile", "VALPOTREAT CR 300 therapy", "VALPOTREAT CR 300 tablets", "Administration Instructions", "gastrointestinal discomfort", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1908, "imageuri": "https://productimages.withfloats.com/actual/666c0efef068be46bdec91c1.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0efef068be46bdec91c1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:35:55.629Z", "updatedon": "2024-06-29T12:22:31.565Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-300-/1908", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 300 mg", "VALPOTREAT CR 300", "", "VALPOTREAT CR 300", "valprol cr 300 side effects", "valprol cr 300 generic name", "valprol cr 300 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0dc4a20cb421407442bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 200 ", "description": "VALPOTREAT CR 200 \nSodium Valproate CR 200 mg\nIntroduction:\n\nVALPOTREAT CR 200 contains Sodium Valproate, a widely used anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 200mg, VALPOTREAT CR 200 is designed to provide sustained therapeutic effects for the management of epilepsy and bipolar disorder, improving the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 200 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer in the treatment of bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 200 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This helps in achieving better symptom control and improving adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 200 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 200 for adults typically starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 200 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 200 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-200-134218", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "need", "life", "GABA", "food", "time", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "severity", "epilepsy", "Benefits", "patients", "adherence", "frequency", "two doses", "medication", "information", "mood swings", "Introduction", "initial dose", "Key Features", "tolerability", "sterispharma", "sterisonline", "CALL/WHATSAPP", "various types", "patient safety", "Initial Dosage", "overall health", "steady release", "liver function", "mood stability", "manic episodes", "dosage strength", "mood stabilizer", "symptom control", "frequent dosing", "absence seizures", "bipolar disorder", "seizure episodes", "clinical response", "treatment regimen", "neuronal activity", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "therapeutic efficacy", "long-term management", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "consistent blood levels", "gamma-aminobutyric acid", "typical maintenance dose", "complex partial seizures", "favorable safety profile", "VALPOTREAT CR 200 therapy", "VALPOTREAT CR 200 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1907, "imageuri": "https://productimages.withfloats.com/actual/666c0dc8c9162f54a15a020e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0dc8c9162f54a15a020e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:30:44.587Z", "updatedon": "2024-06-26T09:16:37.475Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-200-/1907", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "VALPOTREAT CR 200", "Sodium Valproate CR 200 mg", "valpotreat cr 200 uses in hindi", "valprol cr 200 uses in hindi", "valpotreat cr 200 expiry date", "valpotreat" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c09b805b00e1ad41ca790", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TP MATE 50 ", "description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\n\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-50-133634", "price": 99.0, "discountamount": 29.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "50mg", "25mg", "risk", "EMAIL", "night", "option", "adults", "anxiety", "quality", "symptoms", "severity", "50-100mg", "low dose", "epilepsy", "patients", "Benefits", "200-400mg", "two doses", "condition", "migraines", "Topiramate", "depression", "mood swings", "weight gain", "weight loss", "information", "Key Features", "sterispharma", "Introduction", "initial dose", "sterisonline", "CALL/WHATSAPP", "added benefit", "various types", "mood disorders", "patient safety", "Initial Dosage", "effective dose", "sodium channels", "dosage strength", "migraine attacks", "bipolar disorder", "weight reduction", "neuronal activity", "seizure frequency", "daily functioning", "other medications", "Weight Management", "Regular monitoring", "Mood Stabilization", "TP MATE 50 therapy", "glutamate activity", "TP MATE 50 tablets", "migraine prevention", "long-term management", "Migraine Prophylaxis", "Continued Monitoring", "common starting dose", "many anticonvulsants", "therapeutic efficacy", "Anticonvulsant Action", "usual maintenance dose", "potential side effects", "partial-onset seizures", "GABAergic transmission", "Lennox-Gastaut syndrome", "favorable safety profile", "versatile anticonvulsant", "neurotransmitter activity", "stable therapeutic levels", "Administration Instructions", "mood-stabilizing properties", "consistent dosing schedules", "migraine prophylactic medication", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1905, "imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:13:28.046Z", "updatedon": "2024-06-26T06:01:34.175Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-50-/1905", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TP MATE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TP MATE 50", "", "Topiramate (50mg)", "topiramate uses", "topiramate 50 mg", "topiramate side effects", "topiramate side effects weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }